Submitted by Anonymous (not verified) on 18 August 2023 - 16:17
Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 25/06/2020, Revision: 4, Status: Authorised
Source: